GNECCHI, MASSIMILIANO
 Distribuzione geografica
Continente #
NA - Nord America 2.821
EU - Europa 2.127
AS - Asia 1.303
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 4
SA - Sud America 2
Totale 6.273
Nazione #
US - Stati Uniti d'America 2.798
CN - Cina 1.255
IE - Irlanda 810
IT - Italia 361
FI - Finlandia 290
UA - Ucraina 230
DE - Germania 193
SE - Svezia 108
GB - Regno Unito 45
FR - Francia 37
BE - Belgio 30
CA - Canada 23
IN - India 19
NL - Olanda 10
MU - Mauritius 9
MY - Malesia 6
EU - Europa 5
IR - Iran 5
AU - Australia 4
JP - Giappone 4
RU - Federazione Russa 4
KR - Corea 3
A2 - ???statistics.table.value.countryCode.A2??? 2
IQ - Iraq 2
MK - Macedonia 2
TW - Taiwan 2
VN - Vietnam 2
AT - Austria 1
BR - Brasile 1
CH - Svizzera 1
EE - Estonia 1
ES - Italia 1
HK - Hong Kong 1
MD - Moldavia 1
MN - Mongolia 1
PE - Perù 1
PL - Polonia 1
RO - Romania 1
SA - Arabia Saudita 1
SG - Singapore 1
TR - Turchia 1
Totale 6.273
Città #
Dublin 810
Chandler 686
Nanjing 355
Jacksonville 317
Ashburn 206
Beijing 176
Wilmington 145
Princeton 144
Lawrence 133
Nanchang 130
Helsinki 126
New York 126
Hebei 102
Shenyang 94
Changsha 92
Medford 92
Jiaxing 86
Pavia 80
Ann Arbor 76
Hangzhou 62
Shanghai 47
Boardman 42
Tianjin 42
Milan 37
Woodbridge 28
Brussels 25
Norwalk 23
Dearborn 22
Falls Church 22
Toronto 20
Fairfield 19
Seattle 15
Verona 14
Washington 13
Rome 12
Chieti 10
Redwood City 10
Zhengzhou 10
Catanzaro 7
Des Moines 7
Forlì 7
Guangzhou 7
Kunming 7
Pescara 7
Jinan 6
Pune 6
Utrecht 6
Taizhou 5
Hefei 4
Las Vegas 4
Leuven 4
Mountain View 4
Ningbo 4
Palermo 4
Seri Kembangan 4
Berlin 3
Bologna 3
Ferrara 3
Guardiagrele 3
San Genesio Ed Uniti 3
Seregno 3
St Petersburg 3
Turin 3
Venezia 3
Atlanta 2
Auburn Hills 2
Baghdad 2
Bari 2
Barletta 2
Biassono 2
Bientina 2
Borås 2
Daejeon 2
Desio 2
Dong Ket 2
Eden Prairie 2
Esslingen am Neckar 2
Fairfax 2
Florence 2
Francavilla Al Mare 2
Frankfurt am Main 2
Gunzenhausen 2
Houston 2
Hsinchu 2
Lanzhou 2
Lecco 2
Lodi 2
Milazzo 2
Montoro 2
Mumbai 2
Napoli 2
Prato 2
Quiliano 2
Saint-Fons 2
Tabriz 2
Varese 2
Walnut 2
Adelaide 1
Albenga 1
Alghero 1
Totale 4.638
Nome #
Identificazione di microRNA circolanti specificatamente sovra espressi in corso di infarto miocardico acuto. 213
Cellule staminali mesenchimali fetali isolate da placenta esercitano effetti paracrini cardioprotettivi. 114
Allogeneic Lethally Irradiated Cord Blood Mononuclear Cells in No-Option Critical Limb Ischemia: A “Box of Rain” 84
Studio pilota sull'impiego di cellule CD133+ immunoselezionate per il trattamento di vasculopatie periferiche. 80
Human fetal mesenchymal stem cells protect cardiac myocytes against hypoxia/reoxygenation injury 77
Rat experimental model of myocardial ischemia/reperfusion injury: an ethical approach to set up the analgesic management of acute post-surgical pain 73
Gene and cell-based therapies for heart disease 69
Identificazione di fattori paracrini e cardioprotettivi mediante analisi combinata del trascrittoma e del proteoma di cellule staminali mesenchimali fetali. 68
The cardioprotective paracrine effects exerted by human mesenchymal stem cells are negatively influenced by donor age 66
Conditioned medium from human amniotic mesenchymal stromal cells limits infarct size and enhances angiogenesis 66
Adult stem cell-based therapy for the heart 65
The cardioprotective paracrine effects exerted by human mesenchymal stem cells are negatively influenced by donor age 65
Novel experimental protocol to study area at risk, infarct size, immunohistochemistry and tissue protein content on the same rodent heart. 65
Mesenchymal stem cell therapy for heart disease. 65
Cord blood derived endothelial progenitor cells: a superior buiding company in angiogenesis market. 65
Concomitant overexpression of IGF1 and BMP2 in mesenchymal stem cells mediates cytoprotection through both autocrine and paracrine activation of Akt, Erk1/2 and SMAD1/5/8 pathways. 64
Improved transduction efficiency of human amniotic mesenchymal stem cells using optimized lentiviral vectors 64
Soluble factors released by human mesenchymal stem cells of fetal origin lead to cardiomyocyte protection through the inhibition of pro-apoptotic signaling 63
Identification of cardioprotective factors produced by fetal mesenchymal stem cells through a combined transcriptomic and proteomic approach. 63
Impiego di cellule staminali mesenchimali in cardiologia. 62
Overexpression of growth factors to improve cardiac differentiation of human mesenchymal stem cells derived from the amniotic membrane 60
L'età influenza negativamente gli effetti paracrini caridoprotettivi mediati da cellule staminali mesenchimali. 59
Testing the paracrine properties of human mesenchymal stem cells using conditioned medium 59
Donor Age Negatively Influences Cytoprotective but Not Proangiogenic Paracrine Properties of Human Mesenchymal Stem Cells. 58
Correction to: Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy (Internal and Emergency Medicine, (2020), 15, 8, (1457-1465), 10.1007/s11739-020-02493-y) 58
Mesenchymal stem cell therapy for heart disease. 57
Synthetic extracellular matrix mimic hydrogel improves efficacy of mesenchymal stromal cell therapy for ischemic cardiomyopathy. 57
Combined transcriptomic and proteomic approach identifies several putative paracrine factors of fetal mesenchymal stem cells. 56
PBMC microRNA-155 is up-regulated in chronic hemodialysis patients. 56
Cord blood derived endothelial progenitor cells: time dependent in vitro generation capacity. 55
IRES-based lentivirus co-espressing TGFbeta1 and FGF2 improves cell survival and angiogenesis in bone marrow-derived mesenchymal stem cells. 55
Combination of miRNA499 and miRNA133 exerts a synergic effect on cardiac differentiation 55
Strategies for reducing door to balloon time in patients with acute myocardial infarction undergoing primary angioplasty: the Pavia experience 55
Cytokine-induced mobilization of circulating endothelial progenitor cells enhances repair of injured arteries 54
Paracrine mechanisms of mesenchymal stem cells in tissue repair 53
Enhancing the cardiomyogenic potential of human mesenchymal stem cells by modulation of miR expression. 53
Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction and conditioned media production 52
Amyloidogenic light chains induce human cardiac fibroblast toxicity through alteration of mitochondrial functionality 52
Protocols for in vitro differentiation of human mesenchymal stem cells into osteogenic, chondrogenic and adipogenic lineages 52
Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell mediated cardiac repair and functional improvement 51
La contemporanea overespressione di miRNA499 e miRNA133 induce il differenziamento in senso cardiomiocitario di cellule staminali pluripotenti. 51
MicroRNA133 and microRNA499 exert synergistic effect on cardiac differentiation 51
Vascular remodeling in health and disease 50
Endothelium-targeted gene and cell based therapy for cardiovascular disease 50
Human fetal mesenchymal stem cells exert more powerful cytoprotective paracrine effects than bone marrow-derived mesenchymal stem cells 49
Long-term clinical outcome after directional coronary atherectomy followed by stem implantation 49
Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention 49
Comparison of Outcomes of Staged Complete Revascularization Versus Culprit Lesion–Only Revascularization for ST-Elevation Myocardial Infarction and Multivessel Coronary Artery Disease 49
Smoker's paradox in ST-elevation myocardial infarction: Role of inflammation and platelets 49
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 49
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 48
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 48
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 48
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi007-A from a Long QT Syndrome type 1 patient carrier of two common variants in the NOS1AP gene 48
Injected adult bone marrow-derived stem cells fuse with cardiomyocytes in the infarcted heart 47
Pentraxin-3 and galectin-1 are key mediators of the cardioprotective paracrine effects exerted by fetal mesenchymal stem cells isolated from human placenta 47
Novel IRES-based lentivirus co-expressing IGF1 and BMP2 enhances both cardiomyogenesis and cytoprotection of bone marrow-derived mesenchymal stem cells 47
Insertion/deletion polymorphism of the Angiotensin I-Converting Enzyme gene and risk of restenosis after directional coronary atherectomy followed by stent implantation 47
Stem cell therapy for heart repair: the paracrine paradigm. 46
microRNA and Cardiac Regeneration 46
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 46
Paracrine mechanisms of stem cell reparative and regenerative actions in the heart 46
Soluble factors released by human mesenchymal stem cells of fetal origin lead to cardiomyocyte protection through the inhibition of pro-apoptotic signaling 45
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 45
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 44
The unfavourable inflammatory response in elderly patients after myocardial infarction: should we talk of 'dysflammaging'? 44
Mesenchymal stem cells overexpressing Akt exhibit enhanced glucose transport and resist hypoxia induced apoptosis 43
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 43
Paracrine action accounts for marked protection of ischemic heart by Akt modified mesenchymal stem cells. 43
Genetic therapies for cardiovascular diseases: where we are and where we are going 43
Direct oral Xa inhibitors versus warfarin in patients with cancer and atrial fibrillation: a meta-analysis 43
Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy 43
Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair 42
Genotype-Phenotype Correlation in Induced Pluripotent Stem Cell (iPSC) Derived Cardiomyocytes Carrying Calmodulin Mutations 42
Donor age negatively influences the cytoprotective paracrine effects exerted by human mesenchymal stem cells 42
Favorable effect of glycoprotein IIbIIIa inhibitors among STEMI patients treated with primary PCI and incomplete ST resolution 42
Risk factors for primary ventricular fibrillation during a first myocardial infarction: Clinical findings from PREDESTINATION (PRimary vEntricular fibrillation and suDden dEath during firST myocardIal iNfArcTION) 42
Liver X receptors a and b are in vivo pathophysiological regulators of renin 41
Cord blood-derived endothelial progenitor cells: a superior building company in the angiogenesis market: P599 41
Enhancing stem cell therapy efficacy through genetic modification 40
Proteotoxicity in cardiac amyloidosis: Amyloidogenic light chains affect the levels of intracellular proteins in human heart cells 40
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi004-A from a carrier of the KCNQ1-R594Q mutation 40
Transplantation of bone marrow-derived cells expressing Akt into infarcted murine heart produces dramatic improvement in cardiac function despite infrequent cellular fusion. 40
Optimized lentiviral transduction of human amniotic mesenchymal stromal cells 39
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation 39
Endothelium targeted gene and cell based therapies for vascular diseases 38
Insertion/deletion polymorphism of the Angiotensin I-Converting Enzyme gene and risk of restenosis after directional coronary atherectomy followed by stent implantation 38
Angiography- versus physiology-guided complete revascularization in patients with STEMI and multivessel disease: who's the better gatekeeper in this setting? 38
Early beneficial effects of bone marrow derived mesenchymal stem cells overexpressing Akt on cardiac metabolism after myocardial infarction 37
Generation of two human induced pluripotent stem cell (hiPSC) lines from a long QT syndrome South African founder population 37
Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study 37
Identification of upregulated microRNAs in the plasma of patients with acute myocardial infarction 36
null 35
Overexpression of Akt in mesenchymal stem cells improves ATP production under hypoxia by increasing glucose uptake and mitochondrial enzymes activity: a possible explanation for increased resistence to apoptosis. 35
Mesenchymal stem cells overesxpressing Akt prevent cardiac metabolic remodelling after infarction. 35
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1 35
Tuning tissue ingrowth into pro-angiogenic hydrogels via dual modality degradation 35
Cell Therapy for Heart Regeneration: Learning from the Past to Build a Brighter Future 35
Neutrophil to platelet ratio: a novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention 35
Long QT Syndrome modelling with cardiomyocytes derived from human-induced pluripotent stem cells 34
Totale 5.224
Categoria #
all - tutte 23.308
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.308


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201935 0 0 0 0 0 0 0 0 0 8 10 17
2019/20201.419 409 579 1 63 9 57 8 73 26 122 65 7
2020/2021582 65 43 17 42 42 78 4 90 41 70 70 20
2021/2022586 6 9 26 7 15 23 9 46 45 16 91 293
2022/20232.147 224 155 37 131 207 211 5 116 947 22 55 37
2023/2024828 99 177 33 62 84 270 33 52 6 12 0 0
Totale 6.472